Cellosaurus cell line BTLA8.2 (CVCL

Cross-references
Cell line name	BTLA8.2
Synonyms	BTLA 8.2
Accession	CVCL_B7F3
Resource Identification Initiative	To cite this cell line use: BTLA8.2 (RRID:CVCL_B7F3)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4123. Monoclonal antibody isotype: IgG1. Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_4032 (P3X63Ag8.653)
Category	Hybridoma
Publications	PubMed=20693422; DOI=10.4049/jimmunol.0902487 Serriari N.-E., Gondois-Rey F., Guillaume Y., Remmerswaal E.B.M., Pastor S., Messal N., Truneh A., Hirsch I., van Lier R.A.W., Olive D. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 185:3140-3148(2010) Patent=US9896507 Olive D., Gondois-Rey F., Serriari N.-E., Pastor S. BTLA antibodies and uses thereof. Patent number US9896507, 20-Feb-2018 Patent=US10005839 Olive D., Pasero C., Gertner-Dardenne J. Antagonist of the BTLA/HVEM interaction for use in therapy. Patent number US10005839, 26-Jun-2018
Encyclopedic resources	Wikidata; Q112929349
Entry history
Entry creation	23-Jun-2022
Last entry update	21-Mar-2023
Version number	3